WorldWideScience

Sample records for propanolamines

  1. Simultaneous determination of cetirizine, phenyl propanolamine and nimesulide using third derivative spectrophotometry and high performance liquid chromatography in pharmaceutical preparations.

    Science.gov (United States)

    Aly, Fatma Ahmed; El-Enany, Nahed; Elmansi, Heba; Nabil, Amany

    2017-10-05

    The combination between cetirizine (CET), phenylpropanolamine (PPA) and nimesulide (NMS) under trade name Nemeriv Cp tablet is prescribed for nasal congestion, cold, sneezing, and allergy. Among all published methods for the three drugs; there is no reported method concerning estimation of CTZ, PPA and NMS simultaneously and this motivates us to develop new and simple methods for their assay in pure form and tablet preparations. Two new methodologies were described for the simultaneous quantification of cetirizine (CTZ), PPA and NMS. Spectrophotometric procedures relies on measuring the amplitudes of the third derivative curves at 238 nm for CTZ, 218 nm for PPA and 305 nm for NMS. The calibration graphs were rectilinear over the ranges of 8-90 µg/mL for CTZ, 20-100 µg/mL for PPA and 20-200 µg/mL for NMS respectively. Regarding the HPLC method; monolithic column (100 mm × 4.6 mm i.d) was used for the separation. The used mobile phase composed of 0.1 M phosphate buffer and methanol in the ratio of 40:60, v/v at pH 7.0. The analysis was performed using UV detector at 215 nm. Calibration curves showed the linearity over concentration ranges of 5-40, 10-100 and 10-120 µg/mL for CTZ, PPA and NMS. Application of the proposed methods to the laboratory prepared tablets was carried out successfully. The results were compared with those obtained from previously published methods and they were satisfactory. Graphical abstract Graphical abstract represents the chemical structures, representative chromatogram for the HPLC separation of a PPA, b NMS and c CTZ and third derivative absorption spectra of a PPA, b NMS and c CTZ for the spectrophotometric method.

  2. 46 CFR Table 151.05 to Subpart 151... - Summary of Minimum Requirements

    Science.gov (United States)

    2010-10-01

    ... Vent F Yes .55-1(e) NA NA G Potassium hydroxide solution, see Caustic potash solution iso-Propanolamine... chlorate solution (50% or less) Atmos. Amb. III 1 i 2 i Integral Gravity Open Open II G-1 NR Vent N No .50...

  3. LC for analysis of two sustained-release mixtures containing cough cold suppressant drugs.

    Science.gov (United States)

    El-Gindy, Alaa; Sallam, Shehab; Abdel-Salam, Randa A

    2010-07-01

    A liquid chromatographic method was applied for the analysis of two sustained-release mixtures containing dextromethorphane hydrobromide, carbinoxamine maleate with either phenylephrine hydrochloride in pharmaceutical capsules (Mix 1) or phenyl-propanolamine, methylparaben, and propylparaben, which bonds as a drug base to ion exchange resin in pharmaceutical syrup (Mix 2). The method was used for their simultaneous determination using a CN column with a mobile phase consisting of acetonitrile-12 mM ammonium acetate in the ratio of 60:40 (v/v, pH 6.0) for Mix 1 and 45:55 (v/v, pH 6.0) for Mix 2.

  4. Synthesis of radiolabeled racemic and enanthiomeric antiarrhythmic agents

    International Nuclear Information System (INIS)

    Hsi, R.S.P.; Stolle, W.T.; Stelzer, L.S.; Hester, J.B.; Perricone, S.C.

    1992-01-01

    Ventricular fibrillation is a leading cause of fatality in patients suffering from cardiovascular disorders. Among approaches to treating cardiac dysrhythmia with medicinal agents is the use of compounds categorized as open-quotes Class IIIclose quotes antiarrhythmic agents to prolong cardiac action potential and increase the refractoriness of cardiac tissues without affecting the sodium current. Investigations into structural requirements necessary for such biological activities led to the synthesis of a series of aniline-propanolamine derivatives. This report describes the preparation of carbon-14 and tritium labeled forms of racemic and enantiomeric forms of these derivatives for conducting drug disposition studies in test animals and human subjects

  5. Stereospecific synthesis of specifically deuterated metoprolol enantiomers from chiral starting materials

    Energy Technology Data Exchange (ETDEWEB)

    Shetty, H.U.; Murthy, S.S.; Nelson, W.L. (Washington Univ., Seattle, WA (USA). Dept. of Medicinal Chemistry)

    1989-10-01

    Enantiomers of metoprolol (1) containing six deuterium atoms in the isopropyl methyl groups ((2R)), two deuterium atoms at C-2 and C-6 of the aromatic ring ((2S)), and two deuterium atoms at C-3 of the propanolamine side chain ((2S)) were prepared. Chiral 2,2-dimethyl-1,3-dioxolane-4-methanols ((4R) and (4S)) were key synthons. Sources of deuterium were ({sup 2}H{sub 6})-isopropyl-amine, 4-(2-methoxyethyl)-2,6-({sup 2}H{sub 2})-phenol, prepared by {sup 2}HCl/{sup 2}H{sub 2}O exchange, and (4S)-2,2-dimethyl-1,3-dioxolane-4-({sup 2}H{sub 2})-4-methanol, prepared by LiAl{sup 2}H{sub 4} reduction of (4S)-methyl 2,2-dimethyl-1,3-dioxolane-4-carboxylate. Enantiomeric excess was greater than 94% for each of the prepared enantiomers, as determined independently by {sup 1}H NMR spectroscopy on diastereomeric derivatives and by chiral column HPLC. (author).

  6. Aminoalcohols and benzoates-friends or foes? Tuning nuclearity of Cu(ii) complexes, studies of their structures, magnetism, and catecholase-like activities as well as performing DFT and TDDFT studies.

    Science.gov (United States)

    Sama, Farasha; Dhara, Ashish Kumar; Akhtar, Muhammad Nadeem; Chen, Yan-Cong; Tong, Ming-Liang; Ansari, Istikhar A; Raizada, Mukul; Ahmad, Musheer; Shahid, M; Siddiqi, Zafar A

    2017-08-14

    Herein, the coordination chemistry of a series of Cu(ii) complexes of various aminoalcohol and benzoate ligands was explored. The pH-dependent reactions of copper(ii) salts with propanolamine (Hpa), N-methyl diethanolamine (H 2 mdea), triethanolamine (H 3 tea), and n butyl-diethanolamine (H 2 budea) were carried out in the presence of various benzoates (benzoic acid, 2-hydroxy benzoic acid, 4-hydroxy benzoic acid, 3-methoxy benzoic acid, and 4-methoxy benzoic acid). The resulting complexes [Cu 2 (pa) 2 (benzoate) 2 ] (1), [Cu 2 (pa) 2 (3-methoxybenzoate) 2 ] (2), [Cu 2 (pa) 2 (4-methoxybenzoate) 2 ] (3), [Cu 2 (H 2 tea) 2 (benzoate) 2 ]·2H 2 O (4), [Cu 2 (H 2 tea) 2 (2-hydroxybenzoate) 2 ]·2H 2 O (5), [Cu 2 (H 3 tea) 2 (4-hydroxybenzoate) 2 ][Cu(Htea) 2 ]·2H 2 O (6), [Cu(H 2 mdea) 2 ][benzoate] 2 (7), [Cu(H 2 mdea) 2 ][4-methoxybenzoate] 2 (8), [Cu(H 2 bdea) 2 ][2-hydroxybenzoate] 2 (9), [Cu 2 (benzoate) 4 (benzoic acid) 2 ] (10), [Cu 2 (4-methoxybenzoate) 4 (CH 3 CN) 2 ]·4CH 3 CN (11) and [Cu 3 (H 2 tea) 2 (benzoate) 2 (NO 3 ) 2 ] (12) were formed as mono-, di- or trinuclear entities depending upon the pH conditions of the reaction. The complexes were characterized employing spectral, magnetic, single-crystal X-ray and DFT/TDDFT studies. 7 and 8 exhibited emission peaks at 510 and 460 nm, respectively, in the solid-state photoluminescence (PL) spectra. The temperature variable magnetic properties of 1-12 revealed the presence of antiferromagnetic (in 1-3 and 7-11) or ferromagnetic interactions (in 4-6 and 12) with Curie constants C = 0.24 (7), 0.28 (8) or 0.35 cm 3 K mol -1 (9) and Weiss constants θ = -0.34 (7), -0.32 (8) or -0.40 (9) K for the mononuclear complexes. The dinuclear complexes demonstrated J values of -89.2(2) (1), -71.1(3) (2), -59.6(1) (3), 98(1) (4), 79.1(2) (5), -85.4(2) (10) and -89.5(2) (11) cm -1 . Strong ferromagnetic interactions were observed in the case of 6 (J = 172(3) cm -1 and zJ' = 2.3(2) cm -1 ), which were comparable with those

  7. Diretrizes para prevenção e tratamento da osteoporose induzida por glicocorticoide Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis

    Directory of Open Access Journals (Sweden)

    Rosa Maria Rodrigues Pereira

    2012-08-01

    , Glucocorticoids/adverse effects, Prednisone/adverse effects, Dose-Response Relationship, Drug, Bone Density/drug effects, Bone Density Conservation Agents/pharmacological action, Osteoporosis/ prevention&control, Calcium, Vitamin D, Vitamin D deficiency, Calcitriol, Receptors, Calcitriol; 1-hydroxycholecalciferol, Hydroxycholecalciferols, 25-Hydroxyvitamin D3 1-alpha-hydroxylase OR Steroid Hydroxylases, Prevention and Control, Spinal fractures/prevention & control, Fractures, Spontaneous, Lumbar Vertebrae/injuries, Lifestyle, Alcohol Drinking, Smoking OR tobacco use disorder, Movement, Resistance Training, Exercise Therapy, Bone density OR Bone and Bones, Dual-Energy X-Ray Absorptiometry OR Absorptiometry Photon OR DXA, Densitometry, Radiography, (Diphosphonates Alendronate OR Risedronate Pamidronate OR propanolamines OR Ibandronate OR Zoledronic acid, Teriparatide OR PTH 1-34, Men AND premenopause, pregnancy, pregnancy outcome maternal, fetus, lactation, breast-feeding, teratogens, Children (6-12 anos, adolescence (13-18 anos. GRAU DE RECOMENDAÇÃO E FORÇA DE EVIDÊNCIA: A Estudos experimentais e observacionais de melhor consistência; B Estudos experimentais e observacionais de menor consistência; C Relatos de casos (estudos não controlados; D Opinião desprovida de avaliação crítica, com base em consensos, estudos fisiológicos ou modelos animais. OBJETIVO: Estabelecer as diretrizes para a prevenção e o tratamento da OPIG.Glucocorticoids (GC are used in almost all medical specialties, and approximately 0.5% of the general population of the United Kingdom receives those medications. With the increased survival of patients with rheumatological diseases, morbidity secondary to the use of those medications represents an important aspect of the management of our patients. The incidences of vertebral and non-vertebral fractures are elevated, ranging from 30% to 50% of the individuals on GC for over three months. Thus, osteoporosis and frailty fractures should be prevented